VasoDynamics is a UK-based pharmaceutical development company with a pipeline of drugs in development to address the side-effects associated with cancer therapies. They are a young company with experienced, diverse executives and a shared vision to improve the standard of cancer care globally. With mounting cost pressures facing healthcare payers all over the world, they are developing cost-efficient medicines which aim to prevent the debilitating, and often dose-limiting, complications of cancer therapy such as skin/mucosa damage and hair-loss. VasoDynamics take great pride in their culture of scientific and development rigour, and their programmes are based on robust science from world-leading research bodies.

Meet Dr Ningfeng Fiona Li, CEO and Founder of Vasodynamics, in our CEO Spotlight video below.